Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)

被引:0
|
作者
Bincy Abraham
Bertus Eksteen
Khan Nedd
Hrishikesh Kale
Dipen Patel
Jennifer Stephens
Ahmed Shelbaya
Richard Chambers
Arif Soonasra
机构
[1] Houston Methodist Hospital,Mailman School of Public Health
[2] Aspen Woods Clinic,undefined
[3] Infusion Associates,undefined
[4] OPEN Health,undefined
[5] Columbia University,undefined
[6] Pfizer,undefined
来源
Advances in Therapy | 2022年 / 39卷
关键词
Biosimilars; Exploratory Treatment Effectiveness Study; Inflammatory bowel disease; Infliximab; Real-world outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2109 / 2127
页数:18
相关论文
共 48 条
  • [1] Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
    Abraham, Bincy
    Eksteen, Bertus
    Nedd, Khan
    Kale, Hrishikesh
    Patel, Dipen
    Stephens, Jennifer
    Shelbaya, Ahmed
    Chambers, Richard
    Soonasra, Arif
    [J]. ADVANCES IN THERAPY, 2022, 39 (05) : 2109 - 2127
  • [2] Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-Up Results From an Observational Real World Study Among Patients With Inflammatory Bowel Disease (ONWARD Study)
    Abraham, Bincy P.
    Eksteen, Bertus
    Nedd, Khan
    Kale, Hrishikesh P.
    Patel, Dipen
    Stephens, Jennifer
    Shelbaya, Ahmed
    Chambers, Richard
    Soonasra, Arif
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S364 - +
  • [3] Treatment and Patient-Reported Outcomes Among People With ALS in the US: Results From a Real-World Study
    Ciepielewska, Malgorzata
    Mellor, Jennifer
    Wright, Jack
    Earl, Lucy
    Thomas, Owen
    Iqbal, Halima
    [J]. MUSCLE & NERVE, 2022, 66 : S40 - S40
  • [4] Secukinumab significantly improves disease severity and patient-reported outcomes up to 1 year of follow-up: Real-world analyses from the Corrona Psoriasis Registry
    Bagel, Jerry
    Germino, Rebecca
    Guana, Adriana
    Herrera, Vivian
    Greenberg, Jeffrey D.
    Litman, Heather J.
    Guo, Ning
    Lebwohl, Mark
    Strober, Bruce E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB122 - AB122
  • [5] Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)
    Bokemeyer, Bernd
    Hlavaty, Tibor
    Allez, Matthieu
    Selema, Pamela
    Moosavi, Shahrzad
    Cadatal, Mary Jane
    Fowler, Heather
    Mueller, Markus
    Liau, Katherine F.
    Gisbert, Javier P.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 791 - 800
  • [6] Secukinumab significantly improves clinical and patient-reported outcomes up to 18 months of follow-up: Real-world evidence from a US psoriasis registry
    Bagel, Jerry
    Behl, Ajay
    Litman, Heather J.
    Medeiros, Rose A.
    Guo, Ning
    Lebwohl, Mark
    Strober, Bruce
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB152 - AB152
  • [7] COMPARISONS OF HOLISTIC PATIENT-REPORTED OUTCOMES BY BIOLOGIC DRUG CLASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REAL-WORLD STUDY IN IBD PARTNERS
    Long, Millie
    Zhang, Xian
    Chen, Wenli
    Lissoos, Trevor
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S23 - S24
  • [8] COMPARISONS OF HOLISTIC PATIENT-REPORTED OUTCOMES BY BIOLOGIC DRUG CLASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REAL-WORLD STUDY IN IBD PARTNERS
    Long, Millie
    Zhang, Xian
    Chen, Wenli
    Lissoos, Trevor
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S38 - S38
  • [9] REAL-WORLD EFFECTIVENESS OF DUPILUMAB ON PATIENT-REPORTED OUTCOMES AND SYMPTOMS IN ASTHMA: 3-MONTH FOLLOW-UP DATA FROM RESPIRE, AN OBSERVATIONAL STUDY WITH PATIENTS RECRUITED FROM A US DUPILUMAB PATIENT SUPPORT PROGRAM
    Cohn, Lauren
    Zhang, Yi
    Wang, Jessie
    Chen, Chao
    Ortiz, Benjamin
    Djandji, Michel
    Zhang, Su
    Yang, Min
    Zeiger, Robert
    [J]. CHEST, 2021, 160 (04) : 29A - 30A
  • [10] Patient-Reported Outcomes, Disease Activity and Safety in 798 Patients with RA Treated with Filgotinib: Up to 1-Year Interim Results from a Prospective Observational Study (FILOSOPHY)
    Burmester, Gerd
    Verschueren, Patrick
    Avouac, Jerome
    Caporali, Roberto F.
    Bevers, Karen
    Betteridge, Neil
    Debray, Thomas P. A.
    De Leonardis, Francesco
    Yuste, Susana Romero
    Zignani, Monia
    Galloway, James
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2611 - 2614